Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-3-8
|
pubmed:abstractText |
The tetrahydro-beta-carboline derived from the condensation of N-methyltryptamine and formaldehyde, a semirigid tricyclic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) tha has been detected in the brains of normal laboratory rats, is biotransformed in a monoamine oxidase B (MAO-B) catalyzed reaction to the corresponding dihydro compound at a rate that is approximately 0.5% of that observed with MPTP. The corresponding tetrahydroindenopyridine in which the double bond beta,gamma to the nitrogen atom retains allylic character is a somewhat better MAO-B substrate. The steric bulk of the nitrogen and methylene bridges in addition to ring strain present in the proposed carbon-centered radical intermediates derived from these types of tricyclic structures may contribute to their relatively poor MAO-B substrate properties. Although no MPTP-like neurotoxic properties were observed following acute administration of the test compounds to mice, we speculate that the chronic accumulation of beta-carbolinium type metabolites could contribute to the rate of nigrostriatal cell loss associated with idiopathic Parkinson's disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenyl-1,2,3,6-tetrahydro...,
http://linkedlifedata.com/resource/pubmed/chemical/Carbolines,
http://linkedlifedata.com/resource/pubmed/chemical/Monoamine Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Monoamine Oxidase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/tryptoline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
473-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2783613-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
pubmed-meshheading:2783613-Animals,
pubmed-meshheading:2783613-Carbolines,
pubmed-meshheading:2783613-Corpus Striatum,
pubmed-meshheading:2783613-Dopamine,
pubmed-meshheading:2783613-Male,
pubmed-meshheading:2783613-Mice,
pubmed-meshheading:2783613-Mice, Inbred C57BL,
pubmed-meshheading:2783613-Monoamine Oxidase,
pubmed-meshheading:2783613-Monoamine Oxidase Inhibitors,
pubmed-meshheading:2783613-Oxidation-Reduction,
pubmed-meshheading:2783613-Pyridines,
pubmed-meshheading:2783613-Structure-Activity Relationship,
pubmed-meshheading:2783613-Substantia Nigra
|
pubmed:year |
1989
|
pubmed:articleTitle |
Studies on semirigid tricyclic analogues of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
|
pubmed:affiliation |
Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco 94143-0446.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|